Owkin
Owkin is a biotechnology company building an autonomous AI scientist to automate biopharmaceutical research and development and support clinical research.
Owkin has raised €295M across 6 funding rounds from 8 investors, most recently a Grant round in Mar 2023. Based in Paris, France; active in Healthtech. Data as of 28 Oct 2026.
Paris, Francewww.owkin.com ↗
Total raised
€295M
€295,292,649
Funding rounds
6
Investors
8
distinct backers
Active since
2018-01
latest 2023-03
Funding by year
EUR raised per yearOwkin — funding by year — interactive chart.
Data table
| Owkin — funding by year | |
|---|---|
| 2017 | €9.2M |
| 2018 | €4.0M |
| 2020 | €16M |
| 2021 | €159M |
| 2022 | €74M |
| 2023 | €33M |
Signals
High confidenceRaise-next likelihood7
base rate 45% for Grant
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood18
base rate 11% (2+ rounds)
- ▲ €100M+ raised
- ▲ 6 rounds raised
- ▲ 9y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
6 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-03-31 | Grant | €33M | French Government | View deal → |
| 2022-06-08 | Series B | €74M | Bristol Myers Squibb | View deal → |
| 2021-11-18 | Other | €159M | Sanofi Ventures | View deal → |
| 2020-06-30 | Series A | €16M | Bpifrance,Mubadala Capital | Ventures US | View deal → |
| 2018-02-01 | Other | €4.0M | View deal → | |
| 2018-01-01 | Series A | €9.2M | Otium Venture alongside Cathay Innovation,Plug and Play and NJF Capital. | View deal → |
Investors
8Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData